Satisfactory Control May Be Retained After Surgery For Intermittent Exotropia

Tuesday, October 23, 2012

Ocular Surgery News

Satisfactory control was achieved in two-thirds of patients undergoing surgical treatment for intermittent exotropia, and most of those patients retained control postoperatively, according to a study.

Full Story

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. None of the above
5. All of the above
Check The Answer

VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product
Smartphone-Based Retinal Screening System
D-EYE, The Modern Day Digital ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Satisfactory Control May Be Retained After Surgery For Intermittent Exotropia

Comments

Quick Quiz

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?

AdGlare RMR Ad

Featured Products

VISUPLAN 500 Non-Contact Tonometer

Smartphone-Based Retinal Screening System

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2